# Study of Apatinib as an Inhibitor of Tumor Angiogenesis

> **NCT00633490** · PHASE1 · UNKNOWN · sponsor: **Fudan University** · enrollment: 18 (estimated)

## Conditions studied

- Tumor

## Interventions

- **DRUG:** apatinib

## Key facts

- **NCT ID:** NCT00633490
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-07
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2008-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00633490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00633490, "Study of Apatinib as an Inhibitor of Tumor Angiogenesis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00633490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*